Cervical cancer trials in China

In China 159 Also abroad 532

159 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiotherapy and Chemotherapy Following Induction Therapy With Enlonstobart Plus Chemotherapy in Patients With Locally Advanced Cervical Cancer.
Where
Tianjin
Age
18 years to 75 years
People
31
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07776821
No phaseNot yet taking people in China
Spatially Fractionated Radiation Therapy for Locally Advanced Cervical Cancer
Where
Shenzhen
Age
18 years and over
People
126
Run by
The University of Hong Kong-Shenzhen Hospital
See details and how to joinNCT07781475
No phaseNot yet taking people in China
Postoperative ctHPV-DNA for Recurrence Prediction and Adjuvant Treatment Decision-Making in Cervical Cancer
Where
Hefei
Age
18 years and over
People
580
Run by
Anhui Provincial Hospital
See details and how to joinNCT07782697
Phase 1Taking people
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
Where
Jinan
Age
18 years to 75 years
People
299 worldwide
Run by
Huahui Health
See details and how to joinNCT07623369
Phase 3Taking people
Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients
Where
Shanghai
Age
18 years to 80 years
People
340
Run by
Ruijin Hospital
See details and how to joinNCT05277688
No phaseTaking people
Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer
Where
Beijing, Langfang
Age
18 years to 75 years
People
154
Run by
Manni Huang
See details and how to joinNCT07684508
Phase 2Taking people
Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemotherapy in Locally Advanced Cervical Cancer: A Single-arm Phase II Trial
Where
Nanjing
Age
18 years to 80 years
People
35
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07731828
No phaseTaking people
Immunotherapy Combined With Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer
Where
Hangzhou
Age
18 years and over
People
30
Run by
Zhejiang Cancer Hospital
See details and how to joinNCT07702838
Phase 2Not yet taking people in China
Hexaminolevulinate Photodynamic Therapy (HAL-PDT) With Deferred Surgery Versus Surgery for High-grade Squamous Intraepithelial Lesions (HSIL)
Where
Changchun, Chengdu, Dongguan, Foshan, Fuzhou, Guangzhou, Hangzhou, Nanjing, Nanning, Shenyang, Shenzhen, Taiyuan, Xiamen, Zhengzhou, Zhongshan
Age
18 days and over
People
230
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07669363
No phaseTaking people
Hematopoietic Stem Cell-containing Autologous Blood Reinfusion for Bone Marrow Protection in Cervical Cancer Patients
Where
Chongqing
Age
18 years to 60 years
People
40
Run by
Chongqing University Cancer Hospital
See details and how to joinNCT05401175
Phase 2Taking people
A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer
Where
Wuhan
Age
18 years to 75 years
People
30
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07424664
Phase 2Not yet taking people in China
Cadonilimab Plus Chemotherapy in LACC: A Prospective, Multicenter, Randomized Phase II Trial
Where
Shanghai
Age
18 years to 75 years
People
134
Run by
Obstetrics & Gynecology Hospital of Fudan University
See details and how to joinNCT07649174
Phase 2Taking people
Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer
Where
Guangzhou
Age
18 years to 70 years
People
103
Run by
Sun Yat-sen University
See details and how to joinNCT07646301
Phase 2Not yet taking people in China
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
Where
Beijing, Harbin
Age
18 years to 80 years
People
227
Run by
GV20 Therapeutics
See details and how to joinNCT07623642
Phase 2/3Taking people
Trop2-targeted immunoPET Imaging of Solid Tumors
Where
Shanghai
Age
18 years to 75 years
People
400
Run by
RenJi Hospital
See details and how to joinNCT06851663
Phase 3Not yet taking people in China
A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer
Where
Fuzhou
Age
18 years to 75 years
People
486
Run by
Fujian Cancer Hospital
See details and how to joinNCT07613567
No phaseTaking people
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Where
Beijing
Age
18 years and over
People
200
Run by
Peking University First Hospital
See details and how to joinNCT07557225
Phase 2Taking people
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
Where
Beijing
Age
18 years and over
People
220
Run by
Peking University People's Hospital
See details and how to joinNCT07586826
Phase 3Taking people
A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT
Where
Wuhan
Age
18 years to 70 years
People
378
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07400536
Phase 1Taking people
A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Where
Changsha
Age
18 years and over
People
88
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT07338487
Phase 2Taking people
A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors
Where
Ji'nan
Age
18 years to 75 years
People
190
Run by
Shanghai Henlius Biotech
See details and how to joinNCT06769152
Phase 1/2Taking people
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Where
Baoding, Beijing, Binzhou, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Guiyang, Hangzhou, Harbin, Hefei, Jinan, Kunming, Linyi, Luoyang, Shanghai, Wuhan, Yunnan
Age
18 years and over
People
350
Run by
Evopoint Biosciences Inc.
See details and how to joinNCT06799637
Phase 3Taking people
A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer
Where
Shanghai
Age
18 years to 75 years
People
720
Run by
Shanghai Shengdi Pharmaceutical Co., Ltd
See details and how to joinNCT07168200
Phase 3Taking people
A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
Where
Guangzhou
Age
18 years and over
People
398
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07418749
Phase 2Taking people
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer
Where
Dalian, Fuzhou, Guangzhou, Hohhot, Jinan, Jining, Nanning, Qingdao, Taiyuan, Zhangzhou
Age
18 years and over
People
89
Run by
Fujian Cancer Hospital
See details and how to joinNCT07256236